Date published: 2026-8-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

LLGL2 Double Nickase Plasmid (h): sc-404667-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • LLGL2 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • LLGL2 Double Nickase Plasmid (h) and LLGL2 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting LLGL2. One or both designs may be available
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: LLGL2 Antibody (A-4): sc-376857
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    LLGL2 Double Nickase Plasmid (h)

    sc-404667-NIC
    20 µg
    $410.00

    LLGL2 Double Nickase Plasmid (h2)

    sc-404667-NIC-2
    20 µg
    $410.00

    LLGL2 (lethal giant larvae homolog 2) encodes a conserved cortical polarity protein that contributes to apical–basal organization, adherens junction stability, and epithelial tissue architecture. It acts within polarity networks linked to the Scribble/Lgl/Dlg module, coordinating membrane trafficking, cytoskeletal dynamics, and asymmetric cell division. Through these processes, LLGL2 influences cell migration and proliferation programs that are frequently rewired during epithelial remodeling and oncogenic transformation. Altered LLGL2 expression or localization has been associated with disrupted junctional integrity and changes in tumor cell behavior in multiple cancer contexts, making it a relevant target for mechanistic studies of polarity loss and metastasis-related phenotypes.

    LLGL2 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the LLGL2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within LLGL2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt LLGL2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of LLGL2-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.